IMPORTED AND AUTOCHTHONOUS KALA-AZAR IN FRANCE

被引:29
作者
JEANNEL, D
TUPPIN, P
BRUCKER, G
DANIS, M
GENTILINI, M
机构
[1] INST HLTH & DEV,NATL CTR IMPORTED DIS,F-75270 PARIS,FRANCE
[2] HOP LA PITIE SALPETRIERE,DEPT TROP DIS & PARASITOL,F-75651 PARIS,FRANCE
关键词
D O I
10.1136/bmj.303.6798.336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - To study the epidemiological, clinical, and biological features of imported and autochthonous kala-azar in France. Design-Prospective survey of all patients in France with kala-azar diagnosed over the two years 1986-7. Information was obtained from parasitology laboratories in regional hospitals and all hospital laboratories and haematology departments capable of diagnosing leishmaniasis in the south of France. Setting-107 public hospitals in France. Patients-89 patients with kala-azar. Interventions-All patients were treated with drugs. In the first instance meglumine antimonate was given to all but two patients. Main outcome measures-Prevalence of the various clinical and biological features of kala-azar; proportion of patients with HIV infection. Results-Half (44) of the patients were children under 8 years old. Seventy patients acquired the disease in France. Imported kala-azar was acquired mainly in Mediterranean countries (9/18 cases). Only 46 (52%) of the patients had all three of the classic associated clinical features of fever, splenomegaly, and hepatomegaly. Anaemia was the commonest biological sign, and the association of the four usual biological signs-anaemia, leucopenia, thrombocytopenia, and hypergammaglobulinaemia -was present in only 14 (33%) of the children under 8 and 26 (60%) adults. Fourteen of the patients over 8 years old were infected with HIV. Conclusion-Doctors must be aware of kala-azar in Mediterranean areas, especially as patients often present without the characteristic features and the disease affects young children preferentially.
引用
收藏
页码:336 / 338
页数:3
相关论文
共 16 条
[1]   TREATMENT OF VISCERAL LEISHMANIASIS WITH PENTAVALENT ANTIMONY AND INTERFERON-GAMMA [J].
BADARO, R ;
FALCOFF, E ;
BADARO, FS ;
CARVALHO, EM ;
PEDRALSAMPAIO, D ;
BARRAL, A ;
CARVALHO, JS ;
BARRALNETTO, M ;
BRANDELY, M ;
SILVA, L ;
BINA, JC ;
TEIXEIRA, R ;
FALCOFF, R ;
ROCHA, H ;
HO, JL ;
JOHNSON, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :16-21
[2]   VISCERAL LEISHMANIASIS UNRESPONSIVE TO ANTIMONIAL DRUGS .2. RESPONSE TO HIGH DOSAGE SODIUM STIBOGLUCONATE OR PROLONGED TREATMENT WITH PENTAMIDINE [J].
BRYCESON, ADM ;
CHULAY, JD ;
MUGAMBI, M ;
WERE, JB ;
GACHIHI, G ;
CHUNGE, CN ;
MUIGAI, R ;
BHATT, SM ;
HO, M ;
SPENCER, HC ;
MEME, J ;
ANABWANI, G .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1985, 79 (05) :705-714
[3]   FATAL CASE OF VISCERAL LEISHMANIASIS IN A TOURIST TO MEDITERRANEAN [J].
HEILMANN, K ;
DOHNERT, G ;
WOHLENBERG, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1971, 96 (01) :36-+
[4]  
HILL FGH, 1975, BRIT MED J, V3, P334
[5]  
JEANNEL D, 1989, LANCET, V2, P804, DOI 10.1016/S0140-6736(89)90868-4
[6]   ECOLOGY OF LEISHMANIASIS IN THE SOUTH OF FRANCE .20. DISPERSAL OF PHLEBOTOMUS-ARIASI TONNOIR, 1921 AS A FACTOR IN THE SPREAD OF VISCERAL LEISHMANIASIS IN THE CEVENNES [J].
KILLICKKENDRICK, R ;
RIOUX, JA ;
BAILLY, M ;
GUY, MW ;
WILKES, TJ ;
GUY, FM ;
DAVIDSON, I ;
KNECHTLI, R ;
WARD, RD ;
GUILVARD, E ;
PERIERES, J ;
DUBOIS, H .
ANNALES DE PARASITOLOGIE HUMAINE ET COMPAREE, 1984, 59 (06) :555-572
[7]  
KINMOND S, 1989, LANCET, V2, P325, DOI 10.1016/S0140-6736(89)90502-3
[8]   VISCERAL LEISHMANIASIS AS AN OPPORTUNISTIC INFECTION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
MONTALBAN, C ;
SEVILLA, F ;
MORENO, A ;
NASH, R ;
CELMA, ML ;
MUNOZ, RF .
JOURNAL OF INFECTION, 1987, 15 (03) :247-250
[9]   IMMUNOTHERAPY FOR PARASITIC DISEASE [J].
NEVA, FA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :55-57
[10]  
OGUNKOLADE BW, 1988, VET PARASITOL, V28, P33, DOI 10.1016/0304-4017(88)90016-7